Zhan Chao Liang

Direttore degli Investimenti presso Shanghai Med-Fine Asset Management Co. Ltd.

40 anni

Consumer Services

Health Technology

Profilo

Zhan Chao Liang is currently the Director at Beijing Mabworks Biotech Co., Ltd.
and the Chief Investment Officer & Partner at Shanghai Med-Fine Asset Management Co. Ltd.
He completed his undergraduate degree from Hlj August First Land Reclamation University in 2008 and his graduate degree from the Academy of Military Medical Sciences in 2011.

Posizioni attive di Zhan Chao Liang

Società	Posizione	Inizio
Beijing Mabworks Biotech Co., Ltd. Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China.	Direttore/Membro del Consiglio	01/05/2016
Shanghai Med-Fine Asset Management Co. Ltd.	Direttore degli Investimenti	01/04/2015

Tutte le posizioni attive di Zhan Chao Liang

Formazione di Zhan Chao Liang

Hlj August First Land Reclamation University	Undergraduate Degree
Academy of Military Medical Sciences	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Zhan Chao Liang

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Beijing Mabworks Biotech Co., Ltd. Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China.	Health Technology
Shanghai Med-Fine Asset Management Co. Ltd.